Y-mAbs Therapeutics, Inc

(NASDAQ:YMAB)

Latest On Y-mAbs Therapeutics, Inc (YMAB):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsY-mAbs' Danyelza gets approval in Brazil for neuroblastomaN/A
2023-05-14 11:30 ESTNewsY-mAbs Therapeutics, Inc. (YMAB) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 22:15 ESTNewsY-mAbs gains as Wedbush upgrades after Q1 resultsN/A
2023-05-08 17:08 ESTNewsY-mAbs Therapeutics GAAP EPS of -$0.15 beats by $0.17, revenue of $20.25M beats by $4.7MN/A
2023-03-31 12:24 ESTNewsY-mAbs Therapeutics, Inc. (YMAB) Q4 2022 Earnings Call TranscriptN/A
2023-03-30 18:11 ESTNewsY-mAbs Therapeutics GAAP EPS of -$2.19 beats by $0.46, revenue of $65.27M beats by $11.88MN/A
2023-03-30 18:11 ESTNewsY-mAbs Therapeutics files for $150M mixed shelf offeringN/A
2023-03-02 08:45 ESTNewsY-mAbs Therapeutics: Omburtamab CRL Hits Hard, But All Is Not OverN/A
2023-02-02 11:07 ESTNewsY-mAbs reaches agreement with EMA on the pediatric investigation plan for naxitamabN/A
2023-01-05 01:40 ESTNewsY-mAbs Therapeutics laying off 35% of workforce as part of strategic restructuringN/A
2022-12-21 12:53 ESTNewsY-mAbs inks contract with WEP for early access for cancer drug Danyelza in EuropeN/A
2022-12-16 12:11 ESTNewsEMA committee rejects Y-mAbs Omblastys for neuroblastomaN/A
2022-12-08 16:19 ESTNewsY-mAbs' Danyelza for neuroblastoma gets approval in ChinaN/A
2022-12-02 13:34 ESTNewsY-mAbs neuroblastoma therapy rejected by FDAN/A
2022-11-13 06:54 ESTNewsY-mAbs Therapeutics, Inc. (YMAB) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 02:51 ESTNewsY-mAbs Therapeutics GAAP EPS of -$0.63 beats by $0.07, revenue of $12.5M beats by $0.49MN/A
2022-11-01 01:42 ESTNewsY-mAbs downgraded to neutral at Wedbush following omburtamab panel voteN/A
2022-10-30 19:27 ESTNewsY-mAbs Therapeutics: Future Upside Dependent On Reinvigorating Danyelza SalesN/A
2022-10-28 23:09 ESTNewsY-mAbs plunges after failing to win FDA AdCom backing for neuroblastoma therapyN/A
2022-10-27 16:48 ESTNewsY-mAbs down 19% on FDA briefing docs on omburtamab, but BofA still optimisticN/A
2022-10-27 00:50 ESTNewsFDA scientists question evidence of efficacy for Y-mAbs' neuroblastoma therapy omburtamabN/A
2022-09-26 10:49 ESTNewsY-mAbs submits application for the approval of Danyelza in BrazilN/A
2022-08-30 12:08 ESTNewsTakeda, Y-mAbs Danyelza gets approval in Israel for neuroblastomaN/A
2022-08-13 03:13 ESTNewsY-mAbs Therapeutics, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-13 03:13 ESTNewsY-mAbs Therapeutics, Inc. (YMAB) CEO Thomas Gad on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 11:57 ESTNewsY-mAbs Therapeutics Q2 GAAP EPS, revenue misses, guidance reiteratedN/A
2022-07-12 17:47 ESTNewsY-mAbs gets FDA nod to begin phase 1 study of GD2-SADA for certain cancersN/A
2022-06-09 02:42 ESTNewsY-mAbs Therapeutics (YMAB) Investor PresentationN/A
2022-05-31 13:52 ESTNewsY-mAbs Omblastys gets FDA priority review to treat children with nerve cell cancerN/A
2022-05-30 07:33 ESTNewsY-mAbs Therapeutics: Steady, Small Steps Targeting Rare CancersN/A
2022-05-26 19:58 ESTNewsY-mAbs Therapeutics' naxitamab meets primary endpoint for neuroblastomaN/A
2022-05-16 04:10 ESTNewsY-mAbs Therapeutics, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-15 02:04 ESTNewsY-mAbs Therapeutics, Inc. (YMAB) CEO Thomas Gad on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 19:04 ESTNewsY-mAbs Therapeutics GAAP EPS of -$0.64 beats by $0.08, revenue of $10.49M misses by $0.61MN/A
2022-04-28 05:18 ESTNewsY-mAbs Therapeutics says CEO to quit, issues Danyelza revenue guidanceN/A
2022-04-01 14:21 ESTNewsY-mAbs resubmits U.S. marketing application for omburtamab to FDAN/A
2022-02-25 16:44 ESTNewsY-MAbs Therapeutics, Inc. (YMAB) CEO Claus Møller on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 23:18 ESTNewsY-mAbs Therapeutics GAAP EPS of -$1.28 misses by $0.59, revenue of $34.9M beats by $24.08MN/A
2022-02-11 11:37 ESTNewsY-mAbs to resubmit U.S. marketing application for neuroblastoma therapy in Q1 2022N/A
2021-11-15 15:21 ESTNewsWarning: YMAB is at high risk of performing badlyN/A
2021-11-06 11:05 ESTNewsY-MAbs Therapeutics, Inc.'s (YMAB) CEO Claus Moller On Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 19:02 ESTNewsY-mAbs Therapeutics EPS misses by $0.10, misses on revenueN/A
2021-10-07 21:15 ESTNewsY-mAbs’ drug for brain tumor gets U.S. FDA rare pediatric disease designationN/A
2021-09-22 11:08 ESTNewsY-mAbs Therapeutics (YMAB) Investor Presentation - SlideshowN/A
2021-09-22 11:07 ESTNewsY-mAbs partner SciClone gains Priority Review of Danyelza in ChinaN/A
2021-08-08 22:23 ESTNewsY-mAbs Therapeutics, Inc. (YMAB) CEO Claus Moller on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 16:09 ESTNewsY-mAbs Therapeutics EPS beats by $0.14, beats on revenueN/A
2021-07-22 09:15 ESTNewsY-mAbs provides regulatory update on omburtamab neuroblastoma treatmentN/A
2021-07-22 09:12 ESTNewsY-mAbs’ 177Lu-omburtamab-DTPA gets EMA recommendation for orphan medicinal product statusN/A
2021-07-22 09:07 ESTNewsY-mAbs says DANYELZA BLA submitted for review in ChinaN/A

About Y-mAbs Therapeutics, Inc (YMAB):

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developing DANYELZA that is in Phase II clinical studies for the treatment of patients with first-line neuroblastoma, third-line neuroblastoma, and in relapsed osteosarcoma; GD2-GD3 vaccine that is in Phase II clinical trial for the treatment of Stage 4 high-risk neuroblastoma; and Omburtamab, a murine monoclonal antibody that is in clinical trials for the treatment of central nervous system/ leptomeningeal metastases from neuroblastoma, desmoplastic small round cell tumor, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. In addition, it is developing Nivatrotamab for the treatment of small cell lung cancer, as well as is in Phase I/II trial for the treatment of refractory GD2 positive adult and pediatric solid tumors; and Lu-omburtamab-DTPA that is in Phase I clinical development for the treatment of medulloblastoma and B7-H3 positive leptomeningeal metastases from solid tumors. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York.

YMAB Quotes by TradingView

See Advanced Chart

General

  • Name Y-mAbs Therapeutics, Inc
  • Symbol YMAB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 125
  • Fiscal Year EndDecember
  • IPO Date2018-09-21
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ymabs.com
View More

Valuation

  • Forward PE 31.35
  • Price/Sales (Trailing 12 Mt.) 71.77
  • Price/Book (Most Recent Quarter) 15.27
  • Enterprise Value Revenue 72.53
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.62
  • Next Year EPS Estimate -$1.65
  • Next Quarter EPS Estimate -$0.07
  • Operating Margin -578%
  • Return on Assets -43%
  • Return on Equity -78%
  • Revenue 20.75 million
  • Earnings Per Share -$1.83
  • Revenue Per Share $0.52
  • Gross Profit 18.55 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.57 billion
  • EBITDA -60318000
  • PE Ratio -25.91
  • Analyst Target Price $59.33
  • Book Value Per Share $2.60
View More

Share Statistics

  • Shares Outstanding 43.53 million
  • Shares Float 28.1 million
  • % Held by Insiders 3348%
  • % Held by Institutions 61.3%
  • Shares Short 2.9 million
  • Shares Short Prior Month 2.23 million
  • Short Ratio 9.98
  • Short % of Float 9%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.31
  • 52 Week High $55.22
  • 52 Week Low $16.34
  • 50 Day Moving Average 40.2
  • 200 Day Moving Average 43.86
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Y-mAbs Therapeutics, Inc (YMAB) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Y-mAbs Therapeutics, Inc (YMAB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.48-$0.5410.68%
2020-09-302020-11-05$N/A-$0.82-$0.77-6.84%
2020-06-302020-08-06$N/A-$1.01-$0.66-53.15%
2020-03-312020-05-07$N/A-$0.66-$0.61-8.41%
2019-12-312020-03-12$N/A-$0.61-$0.655.73%
2019-09-302019-11-13$N/A-$0.70-$0.54-29.15%
2019-06-302019-08-14$N/A-$0.53-$0.49-8.16%
2019-03-312019-05-10$N/A-$0.47-$0.39-19.75%
2018-12-312019-03-22$N/A-$0.42-$0.34-23.53%
2018-09-302018-11-13$N/A-$0.42-$0.36-16.67%

Y-mAbs Therapeutics, Inc (YMAB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Y-mAbs Therapeutics, Inc (YMAB) Chart:

Y-mAbs Therapeutics, Inc (YMAB) News:

Below you will find a list of latest news for Y-mAbs Therapeutics, Inc (YMAB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Y-mAbs Therapeutics, Inc (YMAB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-162.58.8CALL0 00TRUE00
2025-05-1650.35CALL0 25490.27FALSE00
2025-05-167.50.1CALL0 12431.72FALSE00
2025-05-16100.05CALL0 144666.98FALSE00
2025-05-1612.50.25CALL0 121513.36FALSE00
2025-05-16151CALL0 110FALSE00
2025-05-1617.50.3CALL0 1530FALSE00
2025-05-16200.35CALL0 120FALSE00
2025-05-1622.51.6CALL0 80FALSE00
2025-05-16250.7CALL0 50FALSE00
2025-05-16300.5CALL0 60FALSE00
2025-05-162.50.2PUT0 100FALSE00
2025-05-1651.15PUT2 10303.23TRUE1.150
2025-05-167.53.3PUT0 0654.78TRUE00
2025-05-16101.8PUT0 41004.63TRUE00
2025-05-1612.50PUT0 1685.92TRUE00
2025-05-16150PUT0 01138.07TRUE00
2025-05-1617.50PUT0 01101.26TRUE00
2025-05-16200PUT0 01195.08TRUE00
2025-05-1622.50PUT0 01082.15TRUE00
2025-05-16250PUT0 01210.11TRUE00
2025-05-16300PUT0 0807.91TRUE00
2025-06-202.50CALL0 0390.06TRUE00
2025-06-2051.38CALL0 15284.28FALSE00
2025-06-207.50.76CALL0 15633.19FALSE00
2025-06-20100CALL0 0680.2FALSE00
2025-06-202.50PUT0 0701.58FALSE00
2025-06-2050PUT0 0163.64TRUE00
2025-06-207.50PUT0 0303.69TRUE00
2025-06-20100PUT0 0337.14TRUE00
2025-08-152.50CALL0 0248.57TRUE00
2025-08-1550.2CALL1 4457.66FALSE0.20
2025-08-157.50.5CALL0 12404.98FALSE00
2025-08-15100.55CALL0 4435.15FALSE00
2025-08-1512.50CALL0 0456.98FALSE00
2025-08-15150.2CALL0 194473.96FALSE00
2025-08-1517.50CALL0 0487.79FALSE00
2025-08-152.50PUT0 0263.15FALSE00
2025-08-1550.95PUT0 1044.6TRUE00
2025-08-157.51.75PUT0 1102.53TRUE00
2025-08-15103PUT0 1151.91TRUE00
2025-08-1512.50PUT0 0191.77TRUE00
2025-08-15150PUT0 0232.89TRUE00
2025-08-1517.50PUT0 0255.81TRUE00
2025-11-212.51.9CALL2 193.81TRUE1.90
2025-11-2150CALL0 0255.54FALSE00
2025-11-217.50.5CALL0 1599.85FALSE00
2025-11-212.50PUT0 0186.76FALSE00
2025-11-2151.2PUT0 292.72TRUE00
2025-11-217.50PUT0 0143.46TRUE00

Latest YMAB Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST8$11.155
Jun 13, 2022 7:59 PM EST100$11.155
Jun 13, 2022 7:59 PM EST100$11.155
Jun 13, 2022 7:59 PM EST1$11.16
Jun 13, 2022 7:59 PM EST30$11.155

Y-mAbs Therapeutics, Inc (YMAB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920079017/0001104659-20-079017-index.htm
2019-10-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1722964/000000000019014361/0000000000-19-014361-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000083423720008236/0000834237-20-008236-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000083423720009085/0000834237-20-009085-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000090221920000346/0000902219-20-000346-index.htm
2018-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000092189518002952/0000921895-18-002952-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000092189519002358/0000921895-19-002358-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000092189520000559/0000921895-20-000559-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1722964/000104746919002749/0001047469-19-002749-index.htm
2019-10-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1722964/000104746919005954/0001047469-19-005954-index.htm
2019-10-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1722964/000104746919005986/0001047469-19-005986-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1722964/000104746920002613/0001047469-20-002613-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465918058483/0001104659-18-058483-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918058742/0001104659-18-058742-index.htm
2018-10-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918059730/0001104659-18-059730-index.htm
2018-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465918063426/0001104659-18-063426-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465918065289/0001104659-18-065289-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465918067760/0001104659-18-067760-index.htm
2018-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072154/0001104659-18-072154-index.htm
2018-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072378/0001104659-18-072378-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072813/0001104659-18-072813-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072814/0001104659-18-072814-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072815/0001104659-18-072815-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072816/0001104659-18-072816-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072817/0001104659-18-072817-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918072818/0001104659-18-072818-index.htm
2018-12-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465918073834/0001104659-18-073834-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919001814/0001104659-19-001814-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919008749/0001104659-19-008749-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919014072/0001104659-19-014072-index.htm
2019-03-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919016808/0001104659-19-016808-index.htm
2019-03-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919016819/0001104659-19-016819-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919020890/0001104659-19-020890-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919025078/0001104659-19-025078-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919028603/0001104659-19-028603-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919029145/0001104659-19-029145-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919029305/0001104659-19-029305-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919029775/0001104659-19-029775-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919032419/0001104659-19-032419-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919033803/0001104659-19-033803-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919034296/0001104659-19-034296-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919034784/0001104659-19-034784-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919035666/0001104659-19-035666-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919035667/0001104659-19-035667-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919035668/0001104659-19-035668-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919035670/0001104659-19-035670-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919035671/0001104659-19-035671-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919035672/0001104659-19-035672-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919037424/0001104659-19-037424-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919037575/0001104659-19-037575-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919038429/0001104659-19-038429-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919038430/0001104659-19-038430-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919039494/0001104659-19-039494-index.htm
2019-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919039829/0001104659-19-039829-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919040801/0001104659-19-040801-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919041459/0001104659-19-041459-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919044304/0001104659-19-044304-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919045917/0001104659-19-045917-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919046654/0001104659-19-046654-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919046923/0001104659-19-046923-index.htm
2019-08-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919047282/0001104659-19-047282-index.htm
2019-08-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919047283/0001104659-19-047283-index.htm
2019-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919047287/0001104659-19-047287-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919047982/0001104659-19-047982-index.htm
2019-08-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919048147/0001104659-19-048147-index.htm
2019-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919048440/0001104659-19-048440-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919048929/0001104659-19-048929-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919049317/0001104659-19-049317-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919050400/0001104659-19-050400-index.htm
2019-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919050729/0001104659-19-050729-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919053402/0001104659-19-053402-index.htm
2019-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1722964/000110465919053696/0001104659-19-053696-index.htm
2019-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919055605/0001104659-19-055605-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919056422/0001104659-19-056422-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919056720/0001104659-19-056720-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919057968/0001104659-19-057968-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919058623/0001104659-19-058623-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919058992/0001104659-19-058992-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919059128/0001104659-19-059128-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919060104/0001104659-19-060104-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919063325/0001104659-19-063325-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919064562/0001104659-19-064562-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919065429/0001104659-19-065429-index.htm
2019-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919068493/0001104659-19-068493-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919069886/0001104659-19-069886-index.htm
2019-12-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919070242/0001104659-19-070242-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919071679/0001104659-19-071679-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919071894/0001104659-19-071894-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919071895/0001104659-19-071895-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919071896/0001104659-19-071896-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919072041/0001104659-19-072041-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919073414/0001104659-19-073414-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465919074450/0001104659-19-074450-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919077312/0001104659-19-077312-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919077313/0001104659-19-077313-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465919077314/0001104659-19-077314-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920002743/0001104659-20-002743-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920002744/0001104659-20-002744-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920002745/0001104659-20-002745-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920002746/0001104659-20-002746-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920002747/0001104659-20-002747-index.htm
2020-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920004334/0001104659-20-004334-index.htm
2020-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920005251/0001104659-20-005251-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920008059/0001104659-20-008059-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920016243/0001104659-20-016243-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920016786/0001104659-20-016786-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920023381/0001104659-20-023381-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920025381/0001104659-20-025381-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920029210/0001104659-20-029210-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920032477/0001104659-20-032477-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920035357/0001104659-20-035357-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920035949/0001104659-20-035949-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920041575/0001104659-20-041575-index.htm
2020-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920046706/0001104659-20-046706-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920046931/0001104659-20-046931-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920049239/0001104659-20-049239-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920050704/0001104659-20-050704-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1722964/000110465920051776/0001104659-20-051776-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920056887/0001104659-20-056887-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920058106/0001104659-20-058106-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920060887/0001104659-20-060887-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920061618/0001104659-20-061618-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920062619/0001104659-20-062619-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920062623/0001104659-20-062623-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920062625/0001104659-20-062625-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920064258/0001104659-20-064258-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920064263/0001104659-20-064263-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920066408/0001104659-20-066408-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920067768/0001104659-20-067768-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920068699/0001104659-20-068699-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920070319/0001104659-20-070319-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920072912/0001104659-20-072912-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920073029/0001104659-20-073029-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920073854/0001104659-20-073854-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920074795/0001104659-20-074795-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076456/0001104659-20-076456-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076457/0001104659-20-076457-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076458/0001104659-20-076458-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076460/0001104659-20-076460-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076461/0001104659-20-076461-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076462/0001104659-20-076462-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076463/0001104659-20-076463-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920076465/0001104659-20-076465-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920079017/0001104659-20-079017-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920081221/0001104659-20-081221-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920083270/0001104659-20-083270-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920084524/0001104659-20-084524-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920090858/0001104659-20-090858-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920091260/0001104659-20-091260-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920091417/0001104659-20-091417-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920094687/0001104659-20-094687-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920096903/0001104659-20-096903-index.htm
2020-08-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920098451/0001104659-20-098451-index.htm
2020-08-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920099644/0001104659-20-099644-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920101867/0001104659-20-101867-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920105225/0001104659-20-105225-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920106111/0001104659-20-106111-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920111799/0001104659-20-111799-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920112420/0001104659-20-112420-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920112902/0001104659-20-112902-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920113442/0001104659-20-113442-index.htm
2020-10-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920114730/0001104659-20-114730-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920115521/0001104659-20-115521-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920116073/0001104659-20-116073-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920118017/0001104659-20-118017-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1722964/000110465920121792/0001104659-20-121792-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920121843/0001104659-20-121843-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1722964/000110465920121930/0001104659-20-121930-index.htm
2018-10-02SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1722964/000114420418052038/0001144204-18-052038-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1722964/000154478419000003/0001544784-19-000003-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1722964/000155837018009242/0001558370-18-009242-index.htm
2019-03-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1722964/000155837019002375/0001558370-19-002375-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1722964/000155837019008167/0001558370-19-008167-index.htm
2019-10-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1722964/000155837019008756/0001558370-19-008756-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1722964/000155837019010935/0001558370-19-010935-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1722964/000155837020002551/0001558370-20-002551-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1722964/000155837020005750/0001558370-20-005750-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1722964/000155837020009646/0001558370-20-009646-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1722964/000155837020012905/0001558370-20-012905-index.htm
2019-10-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1722964/999999999519002314/9999999995-19-002314-index.htm
2018-10-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1722964/999999999718008036/9999999997-18-008036-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1722964/999999999720000565/9999999997-20-000565-index.htm
2020-02-28SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1722964/999999999720001065/9999999997-20-001065-index.htm

Y-mAbs Therapeutics, Inc (YMAB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Y-mAbs Therapeutics, Inc (YMAB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3348%
Institutional Ownership: 6130%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-14Bo KruseEVP, CFO, Secy & Treas.Sell37,847.0036.031,363,532.790.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920062623/0001104659-20-062623-index.htm
2020-11-03DAVID N GILLDirectorSell4,000.0045.00180,000.000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920121930/0001104659-20-121930-index.htm
2019-08-29Gregory S RaskinDirectorSell5,882.0026.70157,026.460.00https://www.sec.gov/Archives/edgar/data/1722964/000092189519002358/0000921895-19-002358-index.htm
2020-09-10Thomas GadPresident and ChairmanSell13,860.0041.58576,359.780.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920105225/0001104659-20-105225-index.htm
2020-09-11Thomas GadPresident and ChairmanSell13,571.0040.33547,330.640.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920105225/0001104659-20-105225-index.htm
2020-09-14Thomas GadPresident and ChairmanSell22,569.0041.00925,426.050.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920105225/0001104659-20-105225-index.htm
2019-04-09Thomas GadPresident and ChairmanSell800.0026.9321,545.281,090,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919020890/0001104659-19-020890-index.htm
2019-04-09Thomas GadPresident and ChairmanSell99,200.0026.022,581,184.001,090,800.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919020890/0001104659-19-020890-index.htm
2020-09-11Thomas GadPresident and ChairmanBuy13,571.002.0027,142.0013,571.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920105225/0001104659-20-105225-index.htm
2020-09-10Thomas GadPresident and ChairmanBuy13,860.002.0027,720.0013,860.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920105225/0001104659-20-105225-index.htm
2018-09-25ASHU TYAGIDirectorBuy430,174.0016.006,882,784.001,392,740.00https://www.sec.gov/Archives/edgar/data/1722964/000110465918058742/0001104659-18-058742-index.htm
2020-05-26Mahiuddin AhmedSr. VP and CSOSell50,000.0039.381,969,235.00150,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920066408/0001104659-20-066408-index.htm
2020-01-15JAMES HEALYDirectorBuy17,778.0011.16198,402.4817,778.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920005251/0001104659-20-005251-index.htm
2020-03-17Pedro Claus Juan Moller-SanChief Executive OfficerBuy1,900.0017.2232,711.541,900.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920035949/0001104659-20-035949-index.htm
2020-05-19Mahiuddin AhmedSr. VP and CSOSell10,000.0039.24392,403.00200,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920064258/0001104659-20-064258-index.htm
2020-05-18Mahiuddin AhmedSr. VP and CSOSell19,492.0039.49769,674.76210,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920064258/0001104659-20-064258-index.htm
2019-10-30JAMES HEALYDirectorBuy90,000.0028.002,520,000.002,194,278.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919059128/0001104659-19-059128-index.htm
2020-09-14Thomas GadPresident and ChairmanBuy22,569.002.0045,138.0022,569.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920105225/0001104659-20-105225-index.htm
2020-05-13Mahiuddin AhmedSr. VP & Chief Scientific OffSell10,508.0037.64395,563.15229,492.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920062619/0001104659-20-062619-index.htm
2020-05-12Mahiuddin AhmedSr. VP and CSOSell20,000.0039.19783,776.00240,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920060887/0001104659-20-060887-index.htm
2020-05-14Bo KruseEVP, CFO, Secy & Treas.Sell28,199.0036.031,015,871.79257,077.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920062623/0001104659-20-062623-index.htm
2020-01-15JAMES HEALYDirectorBuy8,000.0021.45171,600.0025,778.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920005251/0001104659-20-005251-index.htm
2020-05-13Bo KruseEVP, CFO, Secy & Treas.Sell14,724.0037.86557,516.90285,276.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920062623/0001104659-20-062623-index.htm
2020-05-13Bo KruseEVP, CFO, Secy & Treas.Sell19,230.0037.88728,399.7137,847.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920062623/0001104659-20-062623-index.htm
2020-11-03DAVID N GILLDirectorBuy4,000.0011.1644,640.004,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920121930/0001104659-20-121930-index.htm
2019-09-06Johan Wedell-WedellsborgDirectorSell5,791.0027.00156,357.00498,392.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919049317/0001104659-19-049317-index.htm
2019-09-05Johan Wedell-WedellsborgDirectorSell11,452.0027.00309,204.00504,183.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919049317/0001104659-19-049317-index.htm
2019-08-30Johan Wedell-WedellsborgDirectorSell100.0027.002,700.00515,635.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919048440/0001104659-19-048440-index.htm
2019-08-29Johan Wedell-WedellsborgDirectorSell89,066.0026.582,367,374.28515,735.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919048440/0001104659-19-048440-index.htm
2019-08-28Johan Wedell-WedellsborgDirectorSell29,552.0027.02798,495.04604,801.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919047982/0001104659-19-047982-index.htm
2020-11-02Thomas GadPresident and ChairmanSell4,000.0043.69174,768.80630,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920121843/0001104659-20-121843-index.htm
2020-10-15Thomas GadPresident and ChairmanSell4,000.0039.15156,603.60634,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920116073/0001104659-20-116073-index.htm
2019-08-27Johan Wedell-WedellsborgDirectorSell19,805.0027.18538,299.90634,353.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919047982/0001104659-19-047982-index.htm
2020-10-01Thomas GadPresident and ChairmanSell4,000.0038.88155,524.40638,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920111799/0001104659-20-111799-index.htm
2020-09-15Thomas GadPresident and ChairmanSell4,000.0040.81163,224.80642,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920106111/0001104659-20-106111-index.htm
2020-09-01Thomas GadPresident and ChairmanSell4,000.0041.60166,390.40646,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920101867/0001104659-20-101867-index.htm
2020-08-17Thomas GadPresident and ChairmanSell4,000.0040.35161,392.00650,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920096903/0001104659-20-096903-index.htm
2020-08-12Thomas GadPresident and ChairmanSell13,000.0039.51513,636.50654,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920094687/0001104659-20-094687-index.htm
2019-08-22Johan Wedell-WedellsborgDirectorSell990.0027.7527,472.50654,158.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919047287/0001104659-19-047287-index.htm
2020-05-14Pedro Claus Juan Moller-SanChief Executive OfficerSell139,154.0036.025,012,995.02657,303.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920062625/0001104659-20-062625-index.htm
2019-08-21Johan Wedell-WedellsborgDirectorSell60,116.0027.831,673,028.28664,147.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919046923/0001104659-19-046923-index.htm
2020-08-11Thomas GadPresident and ChairmanSell37,000.0040.061,482,042.40667,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920094687/0001104659-20-094687-index.htm
2020-08-03Thomas GadPresident and ChairmanSell4,000.0036.51146,026.00704,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920090858/0001104659-20-090858-index.htm
2020-07-15Thomas GadPresident and ChairmanSell4,000.0040.06160,229.20708,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920084524/0001104659-20-084524-index.htm
2020-07-01Thomas GadPresident and ChairmanSell4,000.0042.04168,178.00712,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920081221/0001104659-20-081221-index.htm
2020-06-15Thomas GadPresident and ChairmanSell4,000.0043.45173,811.20716,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920073854/0001104659-20-073854-index.htm
2020-06-04Thomas GadPresident and ChairmanSell4,000.0041.61166,443.60720,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920070319/0001104659-20-070319-index.htm
2020-05-27Thomas GadPresident and ChairmanSell50,000.0039.011,950,460.00724,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920067768/0001104659-20-067768-index.htm
2019-08-20Johan Wedell-WedellsborgDirectorSell108,128.0027.422,964,869.76724,263.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919046923/0001104659-19-046923-index.htm
2020-05-18Thomas GadPresident and ChairmanSell4,000.0039.65158,596.00774,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920064263/0001104659-20-064263-index.htm
2020-05-12Thomas GadPresident and ChairmanSell50,000.0039.041,951,935.00778,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920061618/0001104659-20-061618-index.htm
2020-05-13Pedro Claus Juan Moller-SanChief Executive OfficerSell60,846.0037.752,297,125.12796,457.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920062625/0001104659-20-062625-index.htm
2020-05-01Thomas GadPresident and ChairmanSell4,000.0032.35129,404.40828,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920056887/0001104659-20-056887-index.htm
2020-04-13Thomas GadPresident and ChairmanSell4,000.0029.43117,711.20832,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920046931/0001104659-20-046931-index.htm
2020-03-16Thomas GadPresident and ChairmanSell4,000.0018.0172,040.80836,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920035357/0001104659-20-035357-index.htm
2020-03-02Thomas GadPresident & ChairmanSell4,000.0029.18116,713.20840,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920029210/0001104659-20-029210-index.htm
2020-02-18Thomas GadPresident & ChairmanSell4,000.0032.78131,132.80844,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920023381/0001104659-20-023381-index.htm
2020-02-10Thomas GadPresident & ChairmanSell4,000.0033.03132,120.80848,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920016786/0001104659-20-016786-index.htm
2020-01-27Thomas GadPresident & ChairmanSell4,000.0035.06140,223.60852,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920008059/0001104659-20-008059-index.htm
2020-01-13Thomas GadPresident & ChairmanSell4,000.0030.90123,612.00856,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465920004334/0001104659-20-004334-index.htm
2019-12-16Thomas GadPresident and ChairmanSell4,000.0031.54126,176.40860,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919073414/0001104659-19-073414-index.htm
2019-12-02Thomas GadPresident and ChairmanSell4,000.0032.48129,930.40872,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919069886/0001104659-19-069886-index.htm
2019-11-18Thomas GadPresident and ChairmanSell4,000.0028.41113,657.60876,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919065429/0001104659-19-065429-index.htm
2019-11-04Thomas GadPresident and ChairmanSell4,000.0030.10120,418.00880,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919060104/0001104659-19-060104-index.htm
2019-10-21Thomas GadPresident and ChairmanSell4,000.0027.59110,350.80884,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919055605/0001104659-19-055605-index.htm
2019-10-07Thomas GadPresident and ChairmanSell4,000.0025.21100,848.00888,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919053402/0001104659-19-053402-index.htm
2019-09-16Thomas GadPresident and ChairmanSell4,000.0030.59122,375.60892,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919050400/0001104659-19-050400-index.htm
2019-09-03Thomas GadPresident and ChairmanSell4,000.0025.77103,080.80896,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919048929/0001104659-19-048929-index.htm
2019-08-19Thomas GadPresident and ChairmanSell4,000.0027.70110,804.80900,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919046654/0001104659-19-046654-index.htm
2019-08-05Thomas GadPresident and ChairmanSell4,000.0021.7887,105.60904,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919044304/0001104659-19-044304-index.htm
2019-07-22Thomas GadPresident and ChairmanSell4,000.0022.5490,176.80908,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919041459/0001104659-19-041459-index.htm
2019-07-08Thomas GadPresident and ChairmanSell4,000.0022.4089,591.60912,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919039829/0001104659-19-039829-index.htm
2019-06-24Thomas GadPresident and CharimanSell4,000.0021.7787,097.60916,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919037424/0001104659-19-037424-index.htm
2019-06-10Thomas GadPresident and ChairmanSell4,000.0022.7991,166.40920,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919034784/0001104659-19-034784-index.htm
2019-06-03Thomas GadPresident and ChairmanSell4,000.0020.0380,121.20924,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919033803/0001104659-19-033803-index.htm
2019-05-28Thomas GadPresident and ChairmanSell6,000.0020.21121,252.20928,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919032419/0001104659-19-032419-index.htm
2019-05-13Thomas GadPresident and ChairmanSell6,000.0020.61123,647.40934,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919029305/0001104659-19-029305-index.htm
2019-04-11Thomas GadPresident and ChairmanSell150,000.0025.803,870,000.00940,000.00https://www.sec.gov/Archives/edgar/data/1722964/000110465919020890/0001104659-19-020890-index.htm